Cardiostim 2012 Advance Program

2,576 views

Published on

  • Be the first to comment

  • Be the first to like this

Cardiostim 2012 Advance Program

  1. 1. CARDIOSTIM 2010A dva n ce p rogra m 18th World Congress in Cardiac Electrophysiology & C a r d i a c Te c h n i q u e s June 13 > 16 I 2012 Nice • FrAncE Painting by Françoise Persil­­­­lon Advance program www.cardiostim.com In collaboration with www.cardiostim.fr 1
  2. 2. Cardiostim 2012 éditorialEuropean Heart Rhythm Association (EHRA) Program A messageWednesday June 13 / 00:00 AM Wednesday June 13 / 00:00 AM from the Chairman of CardiostimCARDIAC STEM CELLS AND GENE THERAPY NEW IMAGING TECHNIQUESChair: Chair:Cohen I. - Stony Brook, USA Kalman J. - Melbourne, AUSFast V. - Birmingham, USA Mazgalev T.N. - Cleveland, USA• aking Hearts Regenerate M • lectrocardiographic Imaging to Understand Arrhythmia EDear Colleagues, DearCHE Pedrazzini T. - Lausanne, Friends, Mechanisms• ardiac Differentiation of Human Keratinocytes Derived from C Rudy Y. - St. Louis, USAToday is already tomorrow! Plucked Hair Follicles • imulations to Predict Sites of VT Ablation S Trayanova N. A. - come. AdvancesIn Binah O. - were announcing revolutions in the Electrophysiology world for the years to Baltimore, USA are now on the way, and 2010, we Haifa, ISR • RI for Risk Prediction of Arrhythmogenic Areas Mtheir first applications Stem Cells from Patients the 2012 edition of Cardiostim!• nduced Pluripotent will be discussed during with Inherited I Halperin H. - saved by USARoutine ablation procedures for VT/VF, especially during electrical storms in patientsBaltimore, their ICD, robotic and 3D mapping Arrhythmiasand navigation - Madison, USA • hat Are the Clinical Implications? management, transeptal, W new anticoagulants in AF January C. T. for EP and ablation techniques, contact force control,pericardialthe robotic approaches to the left ventricle for CRT, cardiac simulation - Mannheim, DEU arrhythmia mechanisms and• hat Are or Clinical Implications? W Borggrefe M. for understandingCRT, among many others, are some of the major topics that will be introduced Discussion • eneral and debated! G Rosen M. R. - New York, USANew recommendations on palpitation management and CRT implantation and follow-up will be presented. Formerly recognized• General Discussionindications will be revisited, such as vaso-vagal syncope, hypertrophic cardiomyopathy or Brugada syndrome. Lots ofdebates will be organized as shows and you’ll be able to give your opinion through voting systems in many of the programs settled bythe most famous experts.What is unique in Cardiostim is the atmosphere that brings more and more people to this friendly meeting whereattendees can freely express their opinion.That is probably why, despite the international financial crisis, more than a thousand abstracts have been received from all over theworld, and especially from countries that were not present until now in our congress, demonstrating the interest of colleagues keen tocome to Nice to present their data and debate! Congratulations to all authors for their scientific contribution.The EHRA Program Committee members, conducted by Andreas Goette (Leipzig – Germany), participated actively in the abstractselection in addition to the Cardiostim members. Consequently, each abstract has been reviewed by at least 6 experts. The SelectionCommittee rejected 43 % abstracts overall. This year, a smaller number of oral abstract sessions is proposed to enhance the qualityof the presented material. I must congratulate and thank everyone for these difficult tasks!As can be seen along this Advance Program, the global result of the combination of EHRA sessions with the traditional programsproposed by our American friends and the Cardiostim Team is a high standard program that one will remind as the most completeand attractive ever!Our task is to translate this knowledge into understandable and useful information for clinical practice. This is whyCardiostim also proposes educational sessions based on case presentations in the general program as well as dedicated sessions.With the same logics, specific sessions will be dedicated to technicians and nurses.Next June, you will enjoy Cardiostim! The platform to consult and free download ECG and Epidemiology data Philippe Ritter - Chairman http://epdatabank.cardiostim.com www.cardiostim.com 3
  3. 3. springermedizin.de Up-to-date – Qualified – Online Clinical Research in Cardiology • Current and competent survey on the diagnosis and therapy of heart and vascular diseases • Impact Factor 2010: 3.466, rank 31/114 (Journal Citation Reports ® Thomson Reuters) • Official Journal of the German Cardiac Society www.crc.springer.de Extensive online archive! 050357
  4. 4. Cardiostim 2012Congress Highlights in 2012THE EHRA PROGRAM An extensive program was designed by the Scientific Program Committee of EHRA, and will include a total number of 30 sessions.HIGH-TECH ADVANCES Among many others, four sessions will focus on new technologies that will impact our practice in the future with the following topics: understanding of arrhythmia mechanisms and signal processing, computer simulation in electrophysiology and CRT.HIGH STANDARD EDUCATION Educational material is proposed in all programs, based on Case presentations. In the EP and ablation section, a specific program is proposed by George Klein on Saturday June 16. In addition a Program is given in French on devices, and two sessions are dedicated to technicians and nurses.EPDatabank by cardiostim New in Cardiostim! Educational material is available on http://epdatabank.cardiostim.com for your own purposes. Epidemiologic information, ECG tracings, EGMs, etc… can be downloaded for free! Don’t hesitate to submit yours! The platform to consult and free download ECG and Epidemiology data http://epdatabank.cardiostim.com www.cardiostim.com 5
  5. 5. Advance programScientific Organizing CommitteeCARDIOSTIM TEAMPhilippe Ritter (Bordeaux, FRA)Pierre Bordachar, Stéphane Garrigue, Sylvain Reuter, Frédéric Sacher (Bordeaux, FRA), Mark O’Neill (London, GBR),Vincent Probst (Nantes, FRA)David Hayes (Rochester, USA) J.Claude Daubert (Rennes, FRA)Douglas Zipes (Indianapolis, USA) J.Jacques Blanc (Brest, FRA)European Heart Rhythm Association (EHRA)President: Angelo Auricchio (Lugano, CHE)Europace 2013 Program Committee Chairman: Andreas Götte (Magdeburg, DEU)Vice-Chairman: John M. Morgan (Southampton, GBR)Preparation Committee for Scientific ProgramsTo date, will be implemented as we go alongAbi-Samra F. M. USA Butter C. DEU Dobrev D. DEU Gorenek B. TURAdragao P. PRT Calkins H. USA Dodinot B. FRA Gras D. FRAAliot E. FRA Callans D. USA Dolan B. USA Grunnet M. DNKAllessie M. NLD Camm A. J. GBR Dorian P. CAN Guiraudon G. M. CANAlonso C. FRA Cannom D. S. USA Dubner S. ARG Guirgis M. FRAAmman P CHE Cappato R. ITA Duffy H. USA Gulizia M. ITAAntzelevitch C. USA Capucci A. ITA Duytschaever M. BEL Hachiya H. JPNArnar D ICE Carlson M. D. USA Efimov I. R. USA Haigney M. USAAsirvatham S. J. USA Cazeau S. FRA Ehrlich J. DEU Haines D. E. USAAtie J. BRA Cha Y. M. USA Ellenbogen K. USA Haïssaguerre M. FRAAtienza F. ESP Chen S. A. TWN El-Sherif N. USA Halimi F FRAAuricchio A. CHE Cheng J. USA Epstein L. USA Hammill S. C. USABadhwar N. USA Chirife R. ARG Erdogan A. DEU Hasin Y. ISRBehrenbeck T. USA Clemmensen P.M. DNK Ernst S. DEU Hastrup Svendse J DNKBelott P. H. USA Cohen I. USA Exner D. CAN Hatala R. CZEBenditt D. G. USA Cooke D. USA Ezekowitz M. D. USA Hayes D. USABerenfeld O. USA Coronel R. NLD Fast V. USA Healey J. S. USABiffi M. ITA Corrado D. ITA Fedorov V. USA Heidbüchel H. BELBinner L. DEU Cowie M. GBR Fermont L. FRA Helland J. USABlanc J. J. FRA Crijns H. J. NLD Fernandez Lozano I. ESP Hill M. USABlomström-Lundqvist C. WE S Curnis A. ITA Fishman G. I. USA Hindricks G. DEUBoersma L. NLD Danchin N. FRA Flammang D. FRA Hirao K. JPNBongiorni M. G. ITA Darrel F. GBR Franz M. USA Ho I. USABordachar P. FRA Daubert J. C. FRA Friedman P. A. USA Hocini M. FRABorggrefe M. DEU Davies W. GBR Furniss S. GBR Hoffmann E. DEUBoriani G. ITA Davy J. M. FRA Gaita F. ITA Hohnloser S. DEUBotto G. ITA De Chillou C. FRA Gammage M. GBR Hombach V. DEUBoveda S. FRA De Roy L. BEL Garrigue S. FRA Hornberger L. K. USABoyden P. A. USA Deaton C GBR Geelen P. BEL Husser D DEUBrachmann J DEU Defaye P. FRA Geller C. DEU Iacopino S. ITABraunschweig F. SWE Deharo J. C. FRA Gerstenfeld E. USA Ideker R. E. USABreithardt G. DEU Della Bella P. ITA Gilmour R. USA Ishikawa T. JPNBrignole M. ITA Delnoy P. P. NLD Giudici M. USA Israel C. W. DEUBrugada P. BEL Dickstein K. NOR Goette A. DEU Jackman W. M. USABurri H. CHE Diener H. C. DEU Gold M. USA Jahangir A. USA6 www.cardiostim.com
  6. 6. Cardiostim 2012Jaïs P. FRA McGann C. USA Rhode K. GBR Sternick E. BRAJalife J. USA McKenna W. J. GBR Ricci R. ITA Stevenson W. G. USAJanse M. NLD McVenes R. USA Rich M. USA Sticherling C. CHEJansens J. L. BEL Meine M. NLD Rinaldi A. ITA Stone P. H. USAJauvert G. FRA Meinertz T. DEU Rizzo G. ITA Stotts L. USAJordaens L. NLD Mohr F. W. DEU Roberts P. GBR Suga C. JPNJung W DEU Molina L. MEX Roden D. M. USA Sulke N. USAKaab S. DEU Mont L. ESP Rodriguez E. ESP Sutton R. MCOKacet S. FRA Moorman A. NLD Roguin A. ISR Svendsen J. H. DNKKalifa J. USA Morgan J. M. GBR Rohr S. CHE Szili-Török T. NLDKalman J. M. AUS Morillo C. CAN Ronaszéki A. HUN Taborsky M. CZEKautzner J. CZE Moss A. J. USA Rosen M. R. USA Tanel R. USAKay N. USA Munger T. T. USA Rosenbaum D. S. USA Thambo J. B. FRAKeane D. USA Murgatroyd F. D. GBR Rowland E. GBR Thermistocles S. ITAKennergren C. SWE Myerburg R. J. USA Rozkovec A. DEU Thibault B. CANKenny R. A. IRL Naccarelli G. V. USA Rudy Y. USA Thiene G. ITAKirchhof P. DEU Nademanee K. USA Ruffy R. USA Thijs V. BELKleber A. CHE Nakagawa H. USA Ruiz-Granell R. ESP Tomaselli G. F. USAKlein G. J. CAN Nakazato Y. JPN Ruskin J. N. USA Tondo C. ITAKlein H. DEU Nanthakumar K. CAN Sacher F. FRA Trayanova N. USAKlingenheben T. DEU Narayan S. M. USA Sadoul N. FRA Treede H. DEUKlug D. FRA Natale A. USA Saffitz J. E. USA Tristani-Firouzi M. USAKnecht S. BEL Nattel S. CAN Saghy L HUN Tse H. F. CHNKnight B. USA Nerbonne J. USA Saksena S. USA Tseng G. N. USAKottkamp H. DEU Neumann T. DEU Salama G. USA Tubaro M. ITAKrieger D. DNK Neuzil P. CZE Sanders P. FRA Turitto G. USAKrueger M. DEU Nielsen J. C. DNK Sanguinetti M. USA Valiunas V. USAKuck K. H. DEU Nogami A. JPN Santini M. ITA van Gelder I. C. NLDKusumoto F. USA Norihisa T. JPN Santomauro M. ITA Van Gelder B. NLDLa Rovere M. T. ITA Olgin J. USA Savelieva I. GBR Van Wagoner D. R. USALakatta E. USA Olshansky B. USA Saxon L. USA Vardas P. E. GRCLau C. P. CHN O’Neill M. GBR Schaerf R. USA Varma N. USALazarus A. FRA Opthof T. NLD Schalij M. NLD Verrier R. L. CANLazzara R. USA Oseroff O. ARG Scheinman M. USA Vesin J. M. CHELe Heuzey J. Y. FRA Oto A. TUR Schilling R. DEU Viskin S. ISRLeclercq C. FRA Ovsyshcher E. ISR Schleich J. M. FRA Vlietstra R. USALeclercq J-F FRA Oyarzun R CHL Schmidt B. DEU Vogt J. DEULee H. C. USA Packer D. L. USA Schmidt G. DEU Vohra J. K. AUSLeenhardt A. FRA Padeletti L. ITA Schotten U. NLD Vos M. NLDLévy S. FRA Page R. L. USA Schuger C. USA Vrints C. BELLewalter T. DEU Panfilov A. V. NLD Schumacher B. DEU Waldo A. L. USALickfett L. DEU Pappone C. ITA Schwartz P. J. ITA Wallentin L. DEULinde C. M. SWE Parkhomenko A. UKR Schweikert R. USA Weiss J. USALinker N. J. GBR Parry S. W. GBR Schwitter J. CHE Wellens H. J. NLDLip GYH GBR Pedretti R. ITA Semisarian C. AUS Wieling W. NLDLocati E. ITA Pelleg A. USA Sermasant M. FRA Wilber D. J. USALoh P. NDL Piccini J. USA Sethi K. IND Wilde A. M. NLDLondon B. USA Piorkowski C. DEU Shah D. CHE Wilkoff B. L. USALove C. J. USA Poelzing S. DEU Shaw R. USA Willems S. DEULubinski A. POL Pokushalov E RUS Shen W. USA Wolpert C. DEUMabo P. FRA Poole J. E. USA Shivkumar K. USA Xhaet O. FRAMaier L. DEU Pratt C. M. USA Shoda M. JPN Yamada K. USAMalik M. GBR Prinzen F. W. NLD Simantirakis E. N. GRC Yamane T. JPNManolis A. S. GRC Priori S. G. ITA Siu D. CHN Yang Y. USAMansour M. USA Pruvot E. CHE Sloman G. AUS Yu C. M. CHNMantovan R. ITA Prystowsky E. N. USA Smith N. GBR Zannad F. FRAMarcus F. USA Puererfellner H. AUT Sogaard P. DNK Zareba W. USAMarkijarvi M. FIN Quinn T. GBR Sommer T. DEU Zaza A. ITAMaron B. USA Rasmussen L. H. DNK Sperzel J. DEU Zeppenfeld K. NLDMarrouche N. F. USA Raviele A. ITA Squarcia U. ITA Zieman S. USAMartinek M. AUT Rea R. USA Steinbeck G. DEU Zipes D.P. USAMazgalev T. N. USA Reddy V. Y. USA Steinberg J. USA Zupan I. SVNMcCarty J. USA Revishvilli A. RUS Steinhaus D. USAMcElderry T. USA Reynolds D. W. USA Stern S. ISR www.cardiostim.com 7
  7. 7. Advance programIn collaboration with• European Heart Rhythm Association (EHRA)• Société Française de Cardiologie• European Society of Cardiology• Heart Rhythm Society (HRS)• World Society of Arrhythmias WSA/ICPES• International Society for Holter and Noninvasive Electrocardiology (ISHNE)• Groupe Français d’Electrophysiologie et de Stimulation Cardiaque de la Société Française de Cardiologie• Sociedad Asociación Civil Argentina de Estimulación Cardiaca (SADEC)• Asian-Pacific Society of Cardiology• Brazilian Society of Cardiology• Latin-American Society of Pacing and Electrophysiology (SOLAECE)• Artificial Cardiac Electrostimulation Department of the Brazilian Cardiac Surgery Group (DECA)• Associazione Italiana di Aritmologia e Cardiostimolazione (AIAC)• Mediterranean Society of Pacing and Electrophysiology (MESPE)• he RETAC Group (Reunion of European countries for the Treatment of Arrhythmias in Cardiology/Réseau Européen T pour le Traitement des Arythmies Cardiaques)CME ACCREDITATIONEHRA SESSIONS at CARDIOSTIM 2012 are currently under review for accreditation by the European Boardfor Accreditation in Cardiology (EBAC) for external CME credits.The accreditation results will be announced online and in the final program. Subscribe to Cardiostim newsletter ✓ on www.cardiostim.com8 www.cardiostim.com
  8. 8. Cardiostim 2012ContentsEuropean Heart Rhythm Association (EHRA) Program.............................................................................................. P. 10Basic Electrophysiology.............................................................................................................................................. P. 19Complex Electrophysiology and Ablation Techniques.............................................................................................. P. 23• Novel Approaches to Apply Mechanistic Insights to Complex Human ArrhythmiasTreatments for Atrial Fibrillation................................................................................................................................. P. 29• Advances and Controversies in Atrial Fibrillation (ACAF)Noninvasive Electrocardiology.................................................................................................................................... P. 30• Educational Symposium of International Society for Holter and Noninvasive Electrocardiology (ISHNE)Main Trials in the Management of Atrial Fibrillation.................................................................................................. P. 34Acute Cardiac Care: Management of SCD.................................................................................................................. P. 35Pacing, ICDs and CRT.................................................................................................................................................. P. 36Leads............................................................................................................................................................................ P. 43Associate Symposia.................................................................................................................................................... P. 45• Cardiostim / HRS Joint Session• Cardiopace• Vaso Vagal Syncope• Geriatric Cardiology• Asia Pacific Cardiostim Symposium• Palpitations• Fetal Cardiology Symposium• Pediatric Cardiac Electrophysiology• Cardiostim-JHRS Joint Session• Syncope• ICE Program• Italian Cardiostim Symposium• EPIC AllianceIndustry Symposia....................................................................................................................................................... P. 53Symposium STIMUPRAT.............................................................................................................................................. P. 59 The publisher and the Cardiostim organization disclaim any liability for errors or omissions that may come to light, despite the care taken in the production of this Advance Program. www.cardiostim.com 9
  9. 9. Advance programEuropean Heart Rhythm Association (EHRA) ProgramOrganized bythe Scientific Committee of EHRA,Coordination, Program Committee Andreas Götte - Magdeburg, DEUWednesday June 13 / 9:00 - 10:30 Wednesday June 13 / 9:00 - 10:30CRT IN THE 21ST CENTURY. WHAT DO WE NEW INSIGHTS IN BASICS OF ARRHYTHMIASHAVE NOW? STATUS QUO AND QUO VADIS? Chair:Chair: Crijns H. J. - Maastricht, NLDBoriani G. - Bologna, ITA Savelieva I. - London, GBRKuck K. H. - Hamburg, DEU • alcium Handling and Arrhythmias: A Link to Be Targeted C• RT in Ischemic Heart Failure Patients: From Cell Function to C Zaza A. - Milano, ITA Clinical Outcome • Nodes» in the Arrhythmia Pathogenetic Network « Auricchio A. - Lugano, CHE Schotten U. - Maastricht, NLD• RT in Patients with Atrial Fibrillation C • itochondrial Dysfunction and Arrhythmias M Vardas P. E. - Heraklion, GRC O’Rourke B. - Baltimore, USA• wo Years with New Guidelines. Do We Have Unresolved T • linical Evidence and Possible Therapy of These Arrhythmias C Questions? Van Gelder I. C. - Groningen, NLD Dickstein K. - Stavanger, NOR• RT in Narrow QRS C Ponikowski P. - Wroclaw, POLWednesday June 13 / 9:00 - 10:30 Wednesday June 13 / 9:00 - 10:30PACEMAKER THERAPY IN YEAR 2012 ION CHANNELOPATHIESChair: Chair:Simantirakis E. N. - Heraklion, GRC Jalife J. - Ann Arbor, USAOyarzun R. - Santiago, CHL Kaab S. - Munchen, DEU• ow Important Is Minimization of RV Pacing? H • ong QT Syndrome - Types and Therapies L Israel C. W. - Bielefeld, DEU Priori S. G. - Pavia, ITA• R Safe Pacemakers M • rugada Syndrome - Place of Ion Channel Antiarrhythmic B Davy J. M. - Montpellier, FRA Drugs Wolpert C. - Mannheim, DEU• here in the RV Should Ventricular Pacing Be Applied? W Butter C. - Bernau, DEU • Wave Syndromes J Antzelevitch C. - Utica, USA• hould AAI Pacing Be Considered Obsolete? S Nielsen J. C. - Aarhus, DNK • diopathic Ventricular Fibrillation - Does It Exist? I Wilde A. M. - Amsterdam Zuidoost, NLD10 www.cardiostim.com
  10. 10. Cardiostim 2012European Heart Rhythm Association (EHRA) ProgramWednesday June 13 / 11:00 - 12:30 Wednesday June 13 / 11:00 - 12:30CRT: READING THE GUIDELINES WHAT A DEVICE SPECIALIST NEEDS TO KNOWChair: ABOUT HEART FAILUREAuricchio A. - Lugano, CHE Chair:Kirchhof P. - Birmingham, GBR Daubert J. C. - Rennes, FRA Ponikowski P. - Wroclaw, POL• RT in Mild Heart Failure C Linde C. M. - Stockholm, SWE • acing in Heart Failure: What Happens on the Cellular Level? P• RT in Atrial Fibrillation C Vanderheyden M. - Aalst, BEL Sutton R. - Monaco, MCO • ptimal Medical Treatment in Heart Failure O• RT in Patients with Conventional Pacemaker Indications C Cowie M. - London, GBR Burri H. - Geneva, CHE • he Device Patient with End Stage Heart Failure T• RT in Clinical Practice: The European CRT Survey C Fruhwald F. - Graz, AUT Dickstein K. - Stavanger , NOR • ole of Implantable Sensors in Heart Failure Management R Braunschweig F. - Stockholm, SWEWednesday June 13 / 11:00 - 12:30PURKINJE FIBERS AND VENTRICULARARRHYTHMIASChair:Kuck K. H. - Hamburg, DEULeclercq J. F. - Levallois, FRA• rrhythmia of Purkinje Fibers: Specificity of Cellular A Mechanisms Ehrlich J. - Frankfurt, DEU• ffect of Antiarrhythmic Drugs on the Purkinje Network: E Electrophysiological and Pharmacological Aspects Vos M. - Utrecht, NLD• blation of Polymorphic VT in Patients with Structural Heart A Disease TBD• diopathic VF Originating from the Purkinje Network: Ablation I Targets and Long-Term Follow-Up Knecht S. - Brussels, BEL www.cardiostim.com 11
  11. 11. Advance programEuropean Heart Rhythm Association (EHRA) ProgramWednesday June 13 / 14:00 - 15:30 Wednesday June 13 / 16:00 - 17:30NEW EHRA DOCUMENTS ICD THERAPY IN YEAR 2012Chair: Chair:Raviele A. - Venice, ITA Garrigue S. - Bordeaux, FRA Svendsen J. H. - Copenhagen, DNK• alpitations P Raviele A. - Venice, ITA • efibrillation Testing during Implant: To Do or Not to Do? D• leeding Risk B Baensch D. - Rostock, DEU Lip G. Y. - Birmingham, GBR • ow to Reduce Inappropriate Shock Therapy H• ICD for Life’ Initiative-Fighting against Sudden Cardiac Death ‘ Wolpert C. - Mannheim, DEU in Emerging Economies. • eliability of Implantable Devices and Leads - Are They Good R Merkely B. - Budapest, HUN Enough?• enetic Testing G Steinhaus D. M. - Mounds View, USA Priori S. G. - Pavia, ITA • ow Should We Program Tachy Parameters in ICDs. H Zupan I. - Ljubljana, SVNWednesday June 13 / 14:00 - 15:30 Wednesday June 13 / 16:00 - 17:30SUDDEN CARDIAC DEATH IN THE YOUNG STATE-OF-THE ART ON VENTRICULARChair: TACHYCARDIA ABLATIONHeidbüchel H. - Leuven, BEL Chair:Morgan J. M. - Southampton, GBR De Chillou C. - Nancy, FRA Wellens H. J. - Maastrisht, NLD• utopsy Rate and Cause of Death in the Young: A National A Study from Denmark • ndocardial Catheter Ablation of Monomorphic VT: From E Winkel B. G. - Copenhagen, DNK Bench to EP Lab• rugada Syndrome: Not as Dangerous as First Assumed? B Atie J. - Rio do Janeiro, BRA Borggrefe M. - Mannheim, DEU • picardial Approach: A First Line Therapy? E• ow Should We Make a Work-Up in Young Cardiac Arrest H Della Bella P. - Milano, ITA Survivors? • ew Mapping and Ablation Strategies for Catheter Ablation of N Braunschweig F. - Stockholm, SWE VT in Patients with Dilated Cardiomyopathies• oronary Abnormalities and Sudden Cardiac Death C Piorkowski C. - Leipzig, DEU Ho S. Y. - London, GBR • ombined Ablation Endo-Epicardial Approach for VT Ablation C Kottkamp H. - Zurich, CHE12 www.cardiostim.com
  12. 12. Cardiostim 2012European Heart Rhythm Association (EHRA) ProgramThursday June 14 / 09:00 - 10:30 Thursday June 14 / 11:00 - 12:30PREVENTING SUDDEN CARDIAC DEATH WITH HIGHLIGHTS FROM EUROPACE 2011: DEVICERF ABLATION THERAPY, INTERVENTIONAL EP AND MEDICALChair: THERAPYHaïssaguerre M. - Pessac, FRA Chair:Mont L. - Barcelona, ESP Auricchio A. - Lugano, CHE Hindricks G. - Leipzig, DEU• apping and Ablation of Idiopathic Ventricular Fibrillation M Sacher F. - Bordeaux, FRA • nterventional EP I• revention of VF Episodes in Brugada Syndrome by Catheter P Merino J. L. - Madrid, ESP Ablation • harmacotherapy P Merino J. L. - Madrid, ESP Camm A. J. - London, GBR• ombined Endocardial and Epicardial Ablation in Patients with C • acing P ARVD Vardas P. E. - Heraklion, GRC Wissner E. - Hamburg, DEU • efibrillation and CRT-D D• atheter Ablation of Ventricular Electrical Storms C Wolpert C. - Mannheim, DEU Atie J. - Rio do Janeiro, BRAThursday June 14 / 09:00 - 10:30STROKE PREVENTION IN ATRIAL FIBRILLATION:STATE-OF-THE ART AND NEW CONCEPTSChair:Camm A. J. - London, GBRRasmussen L. H. - Aalborg, DNK• asic Science Insights into the Prothrombotic State in Atrial B Fibrillation De Caterina R. - Chieti, ITA• linical Trial Update - What Do the RELY, ROCKET, C ARISTOTLE and AVERROES Trials Tell Us? Lip G. Y. - Birmingham, GBR• oes Aspirin Still Have a Role in Atrial Fibrillation? D Grond M. - Berlin, DEU• hat Should the New Guideline Revisions on Stroke W Prevention Look Like? Kirchhof P. - Birmingham, GBR www.cardiostim.com 13
  13. 13. Advance programEuropean Heart Rhythm Association (EHRA) ProgramThursday June 14 / 14:00 - 15:30 Thursday June 14 / 16:00 - 17:30CRT IMPLANTATION AND FOLLOW-UP: THE CHALLENGES OF THE ASYMPTOMATICEHRA-HRS CONSENSUS STATEMENT PATIENT IN HEREDITARY SYNDROMESChair: Chair:Daubert J.C. - Rennes, FRA Priori S. G. - Pavia, ITASaxon L. - Los Angeles, USA Wolpert C. - Mannheim, DEU• re-Implant Evaluation P • symptomatic Patient with Long QT Syndrome A Brignole M. - Lavagna, ITA Schulze-Bahr E. - Munster, DEU• mplantation I • symptomatic Patient with Brugada Syndrome A Singh J. - Boston, USA Brugada Terradellas P. - Brussels, BEL• re-Discharge Evaluation P • symptomatic Patient with Early Repolarization Syndrome A Leclercq C. - Rennes, FRA Haïssaguerre M. - Bordeaux, FRA• evice and Heart Failure Follow-Up D Israel C.W. - Frankfurt, DEU • symptomatic Patient with Catecholaminergic Polymorphic VT A• esponse to CRT R Wanguemert Perez F. - Las Palmas, ESP Gold M. - Charleston, USA• pecific Issues S Saxon L. - Los Angeles, USAThursday June 14 / 16:00 - 17:30 Thursday June 14 / 16:00 - 17:30CONTEMPORARY CONSIDERATIONS BASED ON TRANSLATIONAL APPROACHES IN ATRIALTECHNOLOGICAL DEVELOPMENTS IN CARDIAC FIBRILLATIONPACING Chair:Chair: Zaza A. - Milano, ITABotto G. - Como, ITA Goette A. - Magdeburg, DEUSutton R. - Monte Carlo, MCO • enes and Mutations in Patients with Lone Atrial Fibrillation: G• hould All Permanent Pacemakers Be MRI Compatible? S Do They Matter? Santini M. - Roma, ITA Olesen M. - Copenhagen, DNK• s Telemonitoring a New Necessity? I • onic Remodelling: From Bench to Bedside I Burri H. - Geneva, CHE Van Gelder I. C. - Groningen, NLD• eadless Pacing: A Step Forward? L • tructural Remodeling: Which Impact for Catheter Ablation? S Roberts P. - Southampton, GBR Schotten U. - Maastricht, NLD• iological Pacemakers: A Futuristic Approach? B • trial and Ventricular Oxidatives Stress during Atrial A Israel C. W. - Bielefeld, DEU Fibrillation Lendeckel U. - Greifswald, DEU14 www.cardiostim.com
  14. 14. Cardiostim 2012European Heart Rhythm Association (EHRA) ProgramFriday June 15 / 09:00 - 10:30 Friday June 15 / 11:00 - 12:30IMPROVING OUTCOMES IN THE CATHETER COMPLICATIONS RELATED TO ATRIALABLATION OF ATRIAL FIBRILLATION FIBRILLATION CATHETER ABLATIONChair: Chair:Kautzner J. - Praha, CZE Gaita F. - Asti, ITAKuck K. H. - Hamburg, DEU Hatala R. - Bratislava, SVK• enervation of the Heart. The Role of gP Ablation in Atrial D • revalence and Predictors of Complications of Radiofrequency P Fibrillation Treatment Catheter Ablation for Atrial Fibrillation Pokushalov E. - Novosibirsk, RUS Kautzner J. - Praha, CZE• arly Ablation of Atrial Fibrillation. Would We Have Better E • atheter Ablation on Uninterrupted Warfarin: Is It Safe? C Long-Term Results in the Future? Schilling R. - London, GBR Kirchhof P. - Birmingham, GBR • ncidence of Silent Cerebral Thromboembolic Lesions after I• atheter Ablation of the Long-Standing Persistent Atrial C Atrial Fibrillation Ablation: Predictive Factors? Fibrillation. Where We Are Now? Scaglione M. - Asti, ITA Willems S. - Hamburg, DEU • ong-Term Rates of Death, Stroke, and Dementia Following L• urrent Standard of Care in Atrial Fibrillation Ablation C Atrial Fibrillation Ablation Jaïs P. - Bordeaux, FRA Day J. - Salt Lake City, USAFriday June 15 / 09:00 - 10:30 Friday June 15 / 11:00 - 12:30THE COMPLEX PACEMAKER IMPLANTATION CONTINUOUS MONITORING IN ATRIALChair: FIBRILLATION MANAGEMENT. NEW SCIENCEDavy J. M. - Montpellier, FRA OR NEW TRUTH?Ponikowski P. - Wroclaw, POL Chair: Lewalter T. - Bonn, DEU• evice Implant in Case of Subclavian Vein Occlusion D Zupan I. - Ljubljana, SVN Bracke F. - Eindhoven, NLD• mplantation of a Pacing System in GUCH Patients I • ymptomatic/Asymptomatic Events after AF Ablation S Morgan J. M. - Southampton, GBR Hindricks G. - Leipzig, DEU• acing Considerations in Pediatric Patients P • nticoagulation/Antiarrhythmic Management after AF Ablation A Cantu F. - Bergamo, ITA Kirchhof P. - Birmingham, GBR• acemaker Therapy after TAVI Procedure P • F Burden in Assessment of Long-Term Success after AF A Wissner E. - Hamburg, DEU Ablation Puererfellner H. - Linz, AUT • anagement of Early Post-Operative Period. Who Will Need M Early Reablation? Pokushalov E. - Novosibirsk, RUS www.cardiostim.com 15
  15. 15. Advance programEuropean Heart Rhythm Association (EHRA) ProgramFriday June 15 / 14:00 - 15:30 Friday June 15 / 16:00 - 17:30ADVANCES IN ROBOTIC AND 3D MAPPING DIAGNOSTIC EVALUATION OF SYNCOPE INTECHNOLOGIES FOR ATRIAL FIBRILLATION SPECIAL PATIENT GROUPSABLATION Chair:Chair: Morgan J. M. - Southampton, GBRKautzner J. - Praha, CZE Theodorakis G. - Athens, GRCSantini M. - Roma, ITA • atients with Bundle Branch Block P• emote Magnetic Catheter Navigation: Is It the «Gold Standard»? R Moya A. - Barcelona, ESP Ernst S. - Hamburg, DEU • yncope in Athletes S• ethods, Efficacy, and Safety of Robotic Catheter Ablation for M Flevari P. - Halandri, GRC Atrial Fibrillation • yncope in the Elderly: Particularities S Pisapia A. - Marseille, FRA Kenny R. A. - Dublin, IRL• hree-Dimensional Rotational Angiography: A New Online T • yncope Unit: A New Necessity? S Imaging Tool Brignole M. - Lavagna, ITA Noelker G. - Bad Oeynhausen, DEU• atheter Ablation of Atrial Fibrillation Using a New Non- C Fluoroscopic Sensor-Guided 3D Navigation Tool Hindricks G. - Leipzig, DEUFriday June 15 / 14:00 - 15:30 Friday June 15 / 16:00 - 17:30MANAGEMENT OF PATIENTS WITH ARRHYTHMIAS IN WOMEN: STATE OF THEDEFIBRILLATOR SHOCKS: STATE-OF-THE ART EVIDENCEChair: Chair:Boriani G. - Bologna, ITA Borggrefe M. - Mannheim, DEUMorgan J. M. - Southampton, GBR Heidbüchel H. - Leuven, BEL• ncidence, Predictors and Impact on Mortality I • anaging Arrhythmias in Pregnancy: What’s in the Guidelines? M van Rees H. - Den Haag, NLD Blomstrom-Lundqvist C. - Uppsula, SWE• CD Configuration and Programming to Optimise Shock I • ender Differences in Atrial Fibrillation G Treatment Mont L. - Barcelona, ESP Katz A. - Ashkelon, ISR • utcomes in Women Undergoing Electrophysiological O• esults of Catheter Ablation in Patients with Shocks R Procedures Arenal Maiz A. - Madrid, ESP Santangeli P. - Austin, USA• ow to Manage Patient Anxiety H • mplantable Cardioverter Defibrillators in Women I Ladwig K. H. - München, DEU Zupan I. - Ljubljana, SVN16 www.cardiostim.com
  16. 16. Cardiostim 2012European Heart Rhythm Association (EHRA) ProgramFriday June 15 / 16:00 - 17:30 Saturday June 16 / 09:00 - 10:30NEW ENERGIES AND TECHNOLOGIES TO TREAT CERTIFICATION: FIGHTING AGAINST INEQUALITYATRIAL FIBRILLATION IN HEALTH CARE ACROSS BORDERSChair: Chair:Davies W. - London, GBR Auricchio A. - Lugano, CHEKuck K. H. - Hamburg, DEU Nielsen J. C. - Aarhus, DNK• apping and Pulmonary Vein Isolation Using the PVAC M • Powerful Tool for Improvement in Health Care A Duytschaever M. - Brugges, BEL Zeppenfeld K. - Leiden, NLD• ryoballoon Pulmonary Vein Isolation Guided by Real-Time PV C • odels to Be Listened: UK M Potential Recording Linker N. J. - Middlesbrough, GBR Hoffmann E. - Munich, DEU • ertification of Allied Professionals C• ow-Level Vagosympathetic Nerve Stimulation: A New Target L Nolan P. - Galway, IRL for Atrial Fibrillation Suppression? • ertification in Europe: Differences with and Lessons from USA C Jackman W. M. - Oklahoma City, USA Arribas Ynsaurriaga F. - Madrid, ESP• inimally Invasive Surgical Techniques: For Which Patients? M La Meir M. - Maastricht, NLD Saturday June 16 / 09:00 - 10:30 DEBATES AND CONTROVERSIES IN THE ANTITHROMBOTIC MANAGEMENT OF ATRIAL FIBRILLATION Chair: Savelieva I. - London, GBR • ow Risk Patients with Atrial Fibrillation Can Be Treated with L No Antithrombotic Therapy: FOR Fauchier L. - Tours, FRA • ow Risk Patients with Atrial Fibrillation Can Be Treated with L No Antithrombotic Therapy: AGAINST Rasmussen L. H. - Aalborg, DNK • ntiplatelet Therapy Should Be Added to Anticoagulant Therapy A in Patients with Atrial Fibrillation and Vascular Disease: FOR Rubboli A. - Bologna, ITA • ntiplatelet Therapy Should Be Added to Anticoagulant Therapy A in Patients with Atrial Fibrillation and Vascular Disease: AGAINST Marin F. - Murcia, ESP www.cardiostim.com 17
  17. 17. Advance programEuropean Heart Rhythm Association (EHRA) ProgramSaturday June 16 / 11:00 - 12:30 Saturday June 16 / 11:00 - 12:30ANTIARRHYTHMIC DRUGS FOR ATRIAL NURSE-LED INTERVENTIONS FOR PATIENTSFIBRILLATION WITH ARRHYTHMIASChair: Chair:Capucci A. - Ancona, ITA Linker N. J. - Middlesbrough, GBRvan Gelder I. C. - Groningen, NLD Zeppenfeld K. - Leiden, NLD• asics of Ion Channel Antiarrhythmic Drugs for Prevention of B • OPE-ICD Trial: Comprehensive Rehabilitation for Patients C Atrial Fibrillation with Implantable Defibrillators Dobrev D. - Heidelberg, DEU Kikkenborg Berg S. - Copenhagen, DNK• asics of Upstream Therapies for Prevention of Atrial Fibrillation B • educing Psychological Distress for Patients with Implantable R Goette A. - Magdeburg, DEU Defibrillators• on Channel Antiarrhythmic Drugs for Prevention of Atrial Fibrillation I Dunbar S. - Atlanta, USA Crijns H. J. - Maastricht, NLD • mplementing a Nurse-Led Atrial Fibrillation Clinic I• pstream Therapies for Prevention of Atrial Fibrillation U Hendriks J. M. L. - Maastricht, NLD Savelieva I. - London, GBR • alpitations: Effectiveness of A Nurse-Led Clinic P Smallwood A. - Wolverhampton, GBRIn parallel with the scientific sessions, EHRA will hold a General Assembly to update members and attendees on its activities, whilemeetings of various committees and working groups will take place throughout the Congress. EHRA Membership 2012, DISCOVER YOUR BENEFITS ON OUR WEB SITE • pecial registration fee for EHRA educational courses S • ree registration for the EHRA Webinars (e-learning) F • 5% discount on EHRA Certification Examinations 1 • 10% off all cardiology publications from Oxford University Press (OUP). • Reduced fee for the EP Europace journal • xclusive access to EHRA Training Fellowships and a selection of EHRA Educational Content Online E • utomatic ESC membership and benefits: Free ESC Pocket Guidelines at the ESC Congress, A Discount prices on the ESC Educational Products, Special subscription prices on ESC Journals (including EHJ), Receive ESC congresses related information, Receive ESC Educational Programme information, A personal European Membership Card (currently for members of some National Cardiac Societies only) • Receiving the EHRA E-newsletter • Voting rights More at WWW.ESCARDIO.ORG/EHRA18 www.cardiostim.com
  18. 18. Cardiostim 2012Basic ElectrophysiologyChairman: D. Zipes - Indianapolis, USA Scientific Committee Ackerman M. - Rochester, USA Nattel S. - Montreal, CAN Anderson M.E. - Iowa City, USA Priori S. G. - Pavia, ITA Antzelevitch C. - Utica, USA Roden D.M. - Nashville, USA Borggrefe M. - Mannheim, DEU Rosen M. R. - New York, USA Boyden P. - New York, USA Rosenbaum D.S. - Cleveland, USA Chen P.S. - Indianapolis, USA Rudy Y. - St Louis, USA Delmar M. - New York, USA Saffitz J. - Boston, USA Ideker R. - Birmingham, USA Schwartz P. J. - Pavia, ITA Jalife J. - Ann Arbor, USA Tomaselli G. - Baltimore, USA Kleber A. - Bern, CHE Trayanova N. A. - Baltimore, USA London B. - Pittsburgh, USA Weiss J. - Los Angeles, USA Mazgalev T.N. - Cleveland, USA Wilde A. M. - Amsterdam Zuidoost, NLD Moss A.J. - Rochester, USA TRANSLATIONAL DISCOVERIES IN CARDIAC ELECTROPHYSIOLOGY: From Cell to BedsideWednesday June 13 / 09:00 - 10:30 Wednesday June 13 / 11:00 - 12:30CARDIAC STEM CELLS AND GENE THERAPY NEW IMAGING TECHNIQUESChair: Chair:Cohen I. - Stony Brook, USA Kalman J. - Melbourne, AUSFast V. - Birmingham, USA Mazgalev T.N. - Cleveland, USA• aking Hearts Regenerate M • lectrocardiographic Imaging to Understand Arrhythmia E Pedrazzini T. - Lausanne, CHE Mechanisms• ardiac Differentiation of Human Keratinocytes Derived from C Rudy Y. - St. Louis, USA Plucked Hair Follicles • imulations to Predict Sites of VT Ablation S Binah O. - Haifa, ISR Trayanova N. A. - Baltimore, USA • RI for Risk Prediction of Arrhythmogenic Areas M• nduced Pluripotent Stem Cells from Patients with Inherited I Halperin H. - Baltimore, USA Arrhythmias • hat Are the Clinical Implications? W January C. T. - Madison, USA Borggrefe M. - Mannheim, DEU• hat Are the Clinical Implications? W • eneral Discussion G Rosen M. R. - New York, USA• General Discussion www.cardiostim.com 19
  19. 19. Advance programBasic ElectrophysiologyWednesday June 13 / 14:00 - 15:30 Thursday June 14 / 09:00 - 10:30MYOCYTE-FIBROBLAST INTERACTIONS IN CONTRIBUTION OF GENETICS TONORMAL AND DISEASED MYOCARDIUM UNDERSTANDING MECHANISMS AND RISKChair: Chair:Kleber A. - Bern, CHE Sanders P. - Adelaide, AUSVos M. - Utrecht, NLD Lazzara R. - Oklahoma City, USA• yocyte Fibroblast Interaction M • xperimental Models to Explain Inherited Diseases E Kohl P. - London, GBR Antzelevitch C. - Utica, USA• yofibroblasts as Arrhythmia Triggers M • athology to Explain Phenotype P Rohr S. - Bern, CHE Basso C. - Padova, ITA• lectromechanical Consequences of Adult Cardiomyocyte E • ellular Electrophysiology to Explain Clinical Phenotypes C Myofibroblast Interactions Napolitano C. - Pavia, ITA Jalife J. - Ann Arbor, USA • hat Are the Clinical Implications? W• hat Are the Clinical Implications? W Moss A. J. - Rochester, USA Duffy H. - Boston, USA • General Discussion• General DiscussionWednesday June 13 / 16:00 - 17:30 Thursday June 14 / 11:00 - 12:30CARDIAC ION CHANNELS AND DOES GENETIC TESTING FOR SUDDEN DEATHMACROMOLECULAR COMPLEXES IN HEALTH HELP IN CLINICAL PRACTICE?AND DISEASE Chair:Chair: Tseng G. N. - Richmond, USAFishman G. - New York, USA Priori S. G. - Pavia, ITAFedorov V. - Columbus, USA • Syndrome• acromolecular Complexes and the Control of Cardiac Ion M Schwartz P. J. - Pavia, ITA Channel Expression and Distribution • rugada Syndrome and CPVT B Abriel H. - Bern, CHE Brugada P. - Aalst, BEL• ntercalated Disc as a Macromolecular Complex Niche and Its I • Hypertrophic Cardiomyopathy Role in ARVC Maron B. - Minneapolis, USA Delmar M. - New York, USA • ut of Hospital Cardiac Arrest O• AGUK Proteins Are Important in Ion Channel Diseases M Chugh S. S. - Los Angeles, USA Hatem S. - Paris, FRA • hat Are the Clinical Implications? W• hat Are the Clinical Implications? W Viskin S. - Tel Aviv, ISR Coronel R. - Amsterdam, NLD• General Discussion20 www.cardiostim.com
  20. 20. Cardiostim 2012Basic ElectrophysiologyThursday June 14 / 14:00 - 15:30 Friday June 15 / 09:00 - 10:30THE INTERCALATED DISC AND ROLE OF CaMKII IN ARRHYTHMIASARRHYTHMOGENIC CARDIOMYOPATHY Chair:Chair: Maier L. - Goettingen, DEUPoelzing S. - Salt Lake City, USA Gilmour R. - Ithaca, USAEhrlich J. - Frankfurt, DEU • aMKII Regulation of Ion Channels C• ased on Science, What Is the Best Name for Arrhythmogenic B Pitt G. - Durham, USA Right Ventricular Cardiomyopathy? • aMKII Regulation of RyR Receptors and Ca Cycling C McKenna W. - London, GBR Wehrens X. H. - Houston, USA• ell-Cell Communication in ARVC C • ole of CaMKII in Cardiac Arrhythmias R Greene K. - Chicago, USA Mohler P. J. - Columbus, USA• rrhythmia Mechanisms and Therapy A • aMKII as a Potential Antiarrhythmic Target C Calkins H. - Baltimore, USA Maier L. - Goettingen, DEU• hat Is Needed for a Cure? W • hat Are the Clinical Implications? W Thiene G. - Padova, ITA Rosenbaum D. S. - Cleveland, USA• hat Are the Clinical Implications? W Marcus F. - Tucson, USAThursday June 14 / 16:00 - 17:30 Friday June 15 / 11:00 - 12:30UNDERSTANDING ATRIAL FIBRILLATION ROLE OF THE AUTONOMIC NERVOUS SYSTEMChair: IN ARRHYTHMOGENESISHocini M. - Bordeaux, FRA Chair:Probst V. - Nantes, FRA Yamada K. - St. Louis, USA Franz M. - Washington, USA• otassium Channel Remodeling P Nattel S. - Montreal, CAN • ympathetic-Vagal Interactions in Conscious Dogs S• emodeling of Calcium Handling R Lin S- F. - Indianapolis, USA Dobrev D. - Heidelberg, DEU • agal Modulation of Atrial Arrhythmias V• Structural Remodeling Po S. - Oklahoma City, USA Allessie M. - Maastricht, NLD • agal Modulation of Inflammation V• hat Are the Clinical Implications? W Sabbah H. - Detroit, USA Natale A. - Austin, USA • hat Are the Clinical Implications? W• General Discussion Goldberger J. - Chicago, USA • General discussion www.cardiostim.com 21
  21. 21. Advance programBasic ElectrophysiologyFriday June 15 / 14:00 - 15:30 Philippe Coumel SessionSMALL CONDUCTANCE CALCIUM-ACTIVATED Introduction: from Mechanism to Process.POTASSIUM CHANNELS (SK) AND CARDIAC Paradigm Shift?ARRHYTHMIAS Wednesday June 13 / 09:00 - 10:30Chair: ATRIAL FIBRILLATION: DEALING WITHLakatta E. - Baltimore, USAOpthof T. - Utrecht, NLD COMPLEXITY Chair:• hat Are SK Channels? W Guiraudon G.M.- London, CAN Chiamvimonvat N. - Chicago, USA Klein G. J. - London, CAN• K Channels and Ventricular Arrhythmias in Heart Failure S • ntrinsic Autonomic Cardiac Nervous System: New Physiology I Chen P- S. - Indianapolis, USA or Deregulation? Has Neuroablation Predictable Long-Term• K Channels Modulate Cardiogenesis S Effects? Liebau S. - Ulm, DEU Cardinal R. - Montreal, CAN• K Channels and Genetic Basis of Atrial Fibrillation S • nderstanding the Complexity of the Substrate of Human AF U Ellinor P. - Boston, USA Allessie M. - Maastricht, NLD• hat Are the Clinical Implications? W • hen Complexity Beats Ablation? Alternative Interventions to W Myerburg R. J. - Miami, USA Restore Chronotropic Function, and Stroke Prevention Guiraudon G.M. - London, CANFriday June 15 / 16:00 - 17:30ROLE OF miRNAs IN ARRHYTHMIASYNDROMESChair:Grunnet M. - Copenhagen, DNKBoyden P. - New York, USA• hy All the Interest in miRNAs? W Pinto Y. - Amsterdam, NLD• Hypertrophic Cardiomyopathy Ackerman M. - Rochester, USA• ong QT Syndrome L Wilde A. M. - Amsterdam Zuidoost, NLD• Dilated Cardiomyopathy Engelhardt S. - Munich, DEU• hat Are the Clinical Implications? W Roden D. M. - Nashville, USA22 www.cardiostim.com
  22. 22. Cardiostim 2012Complex Electrophysiology and Ablation TechniquesCourse Directors:Scheinman M. - San Fransciso, USAO’Neill M. - London, GBRProbst V. - Nantes, FRASacher F. - Bordeaux, FRAWednesday June 13 / 11:00 - 12:30 Wednesday June 13 / 16:00 - 17:30ATRIAL FIBRILLATION ABLATION I ATRIAL FIBRILLATION ABLATION III• echanisms of Atrial Fibrillation. Implication for Ablation M • ryo Balloon Ablation of AF C Strategies Ellenbogen K. - Richmond, USA Nattel S. - Montreal, CAN • atients Selection for AF Ablation P• eal Time Mapping to Guide Atrial Fibrillation Ablation R O’Neill M. - London, GBR Narayan S. - San Diego, USA • ow to Identify Targets and End-Points for Atrial Fibrillation H• MR Imaging:” Does It Have a Role in Atrial Fibrillation “ Ablation? Ablation? Asirvatham S. J. - Rochester, USA Marrouche N. F. - Salt Lake City, USA • ong-Term Outcome for Atrial Fibrillation Ablation L• trial Fibrillation Ablation for Patients with Long Standing A Knecht S. - Brussels, BEL Persistent Atrial Fibrillation Sanders P. - Adelaide, AUSWednesday June 13 / 14:00 - 15:30ATRIAL FIBRILLATION ABLATION II• ewer Left Atrial Appendage Occlusion and Ligation Devices N for Stroke Prevention: Should They Be Part of an Atrial Fibrillation Procedure? Lee R. J. - San Francisco, USA• picardial Ablation of Atrial Fibrillation E Michaud G. F. - Boston, USA• atheter Ablation of Atrial Fibrillation Using a Non- C Fluoroscopic Sensor Navigation Device Hindricks G. - Leipzig, DEU• ontact Monitoring and New Ablation Toys C Wright M. - London, USA www.cardiostim.com 23
  23. 23. Advance programComplex Electrophysiology and Ablation TechniquesThursday June 14 / 09:00 - 10:30 Thursday June 14 / 14:00 - 15:30ATRIAL FLUTTER ABLATION PAROXYSMAL SUPRAVENTRICULAR• nusual forms (Double Loop, Lower Loop and Intra-Isthmus U TACHYCARDIA ABLATION II Reentry) • blation of the Patient with Atrio-Fascicular Pathways A Mounsey J. P. - Chapel Hill, USA Jackman W. M. - Oklahoma City, USA• pproach to the Ablation of Post Atrial Fibrillation Induced Left A • blation of Atrial Tachycardia/Accessory Pathways from the A Atrial Flutter Aortic Sinus Knecht S. - Brussels, BEL Kuck K. H. - Hamburg, DEU• iagnoses and Ablation of Right Sided Flutter D • ow to Best Diagnose SVT Mechanisms? H Yagi T. - Sendai, JPN Callans D. - Philadelphia, USA • resentation of Complex Cases (SVT) P Scheinman M. - San Fransciso, USAThursday June 14 / 11:00 - 12:30 Thursday June 14 / 16:00 - 17:30PAROXYSMAL SUPRAVENTRICULAR Interactive sessionTACHYCARDIA ABLATION I • nteractive session I• echanisms and Results of Ablative Therapy for Patients with M Badhwar N. - San Francisco, USA Focal Junctional Tachycardia Kalman J. M. - Parkville, AUS Cheng J. - Houston, USA Kuck K. H. - Hamburg, DEU Callans D. - Philadelphia, USA• blation of Complex ANVRT Circuits A Badhwar N. - San Francisco, USA• iagnoses, Therapy and Results of Ablative Therapy for D Patients with Manifest or Concealed Nodo-Fascicular (Ventricular) Pathways Badhwar N. - San Francisco, USA• ocalization and Ablation of Atrial Tachycardias L Kalman J. M. - Parkville, AUS24 www.cardiostim.com
  24. 24. Cardiostim 2012Complex Electrophysiology and Ablation TechniquesFriday June 15 / 09:00 - 10:30 Friday June 15 / 14:00 - 15:30VENTRICULAR TACHYCARDIA ABLATION I VENTRICULAR TACHYCARDIA ABLATION III -• ole of Identifying and Ablating Late Potentials R Debates Jaïs P. - Bordeaux, FRA • atients with 1st Appropriate ICD Shock Should be Treated P• ecognition and Ablation of Intraseptal VT R with Ablation Bogun F. - Ann Arbor, USA PRO: Sapp J. - Halifax, CAN• oes Cardiac MRI Identify the Critical VT Isthmus? D CON: TBD Dickfeld T. - Baltimore, USA • blation of AF: First Line Therapy in Electrical Storms A• he Role of Endocardial Unipolar Recordings for VT Ablation T PRO: Boyle N. - Los Angeles, USA Callans D. - Philadelphia, USA CON: Coromilas J. - New York, USAFriday June 15 / 11:00 - 12:30 Friday June 15 / 16:00 - 17:30VENTRICULAR TACHYCARDIA ABLATION II VENTRICULAR TACHYCARDIA ABLATION IV• atheter Ablation of Fascicular Tachycardia in Practice C • atheter Ablation of Patients with Arrhythmogenic Right C Nogami A. - Kanagawa, JPN Ventricular Dysplasia (ARVD)• atheter Ablation of VT from Papillary Muscles C Reddy V. Y. - Boston, USA Kay N. - Birmingham, USA • atheter Ablation of Patients with VT and Systemic Disease C• F Ablation in Post MI Patients V (Sarcoid/Amyloid/Iron Overload/Myotonic Dystrophy) Snumowski L. - Warsaw, POL Arruda M. - Case Western, USA• ong-Term Outcome after VF Ablation L • blation of the Patient with Ischemic VT A Hocini M. - Bordeaux, FRA Soejima K. - Kawasaki, JPN • ipolar Voltage Map vs. MR for Detection of Myocardial Scar B Gerstenfeld E. P. - Philadelphia, USA www.cardiostim.com 25
  25. 25. Advance programComplex Electrophysiology and Ablation TechniquesCases Discussion in ElectrophysiologyOrganized byKlein G.J. - London, CANSacher F. - Bordeaux-Pessac, FRAO’Neill M. - London, GBRSpeakers are invited to present 1 or 2 cases they found instructive or challenging. The problem might be diagnostic or related toablation complexity.Speakers should be prepared to be interrupted and participate in dialogue during the presentation and consider this in the lengthof their presentation.Saturday June 16 / 9:00 - 10:30 Saturday June 16 / 11:00 - 12:30THE CHALLENGING CASE - Part I THE CHALLENGING CASE - Part IIChair: Chair:Klein G. J. - London, CAN Klein G. J. - London, CANCallans D. - Philadelphia, USA Callans D. - Philadelphia, USAO’Neill M. - London, GBR O’Neill M. - London, GBRSkanes A. - London, CAN Skanes A. - London, CANState-of-the-Art in the Brugada SyndromeOrganized bySacher F. - Bordeaux-Pessac, FRAFriday June 15 / 09:00 - 10:30 Friday June 15 / 11:00 - 12:30THERAPEUTIC OPTIONS IN BRUGADA UNSOLVED ISSUES IN BRUGADA SYNDROMESYNDROME Chair: Wilde A. M. - Amsterdam Zuidoost, NLD• isk Stratification in Brugada Syndrome R Antzelevitch C. - Utica, USA Delise P. - Trevise, ITA• utcome after ICD Implantation O • CN5A: Which Role in Brugada Syndrome? S Sacher F. - Bordeaux-Pessac, FRA Probst V. - Nantes, FRA• F Ablation in Brugada Syndrome V • rugada Syndrome Mechanism: Depolarization/Repolarization B Nademanee K. - Los Angeles, USA or Different Entities with a Same ECG Pattern Postema P.G. - Amsterdam, NLD • alue of Electrophysiological Study for Risk Stratification: The V PRELUDE Study Priori S. G. - Pavia, ITA26 www.cardiostim.com
  26. 26. Cardiostim 2012Complex Electrophysiology and Ablation TechniquesNovel Approaches to Apply Mechanistic Insights to Complex Human ArrhythmiasOrganized byE. Pruvot - Lausanne, CHE S. Narayan - San Diego, USAGoals: To discuss the implementation and practical application of principles and insights from basic science to understand and treathuman arrhythmias. Because the detailed mapping and tissue analyses for in silico, in vitro and in vivo animal models often cannotbe applied in patients, this session will also discuss technical innovations that have enabled successful translational patient studies.Thursday June 14 / 14:00 - 15:30 Thursday June 14 / 16:00 - 17:30MECHANISTIC APPROACHES TO COMPLEX MECHANISTICALLY-GUIDED THERAPIES FORARRHYTHMIAS - PART I: REPOLARIZATION HUMAN CARDIAC FIBRILLATION - PART II -ALTERNANS – TRANSLATING FUNDAMENTAL ATRIAL ARRHYTHMIASOBSERVATIONS TO CLINICAL PRACTICE FOR Chair:ATRIAL AND VENTRICULAR ARRHYTHMIAS Berenfeld O. - Ann Arbor, USAChair:Pruvot E. - Lausanne, CHE • asic Science of Atrial Fibrillatory Sources: The Role of Rotors BNarayan S. - San Diego, USA vs Multiple Wavelets Jalife J. - Ann Arbor, USA• rom Pulsus to Pulseless: The Saga of Cardiac Repolarization F • ocalized Rotors and Focal Beats in Human Atrial Fibrillation L Alternans Narayan S. - San Diego, USA Rosenbaum D. S. - Cleveland, USA • linical Application of Noninvasive Electrocardiographic C• ntermittent Atrial Tachycardia Promotes Repolarization I Imaging (ECGI) Alternans and Susceptibility to AF in a Free-Behaving Sheep Cuculich P. - St Louis, USA Model • lectrogram Correlates of Localized Sources During AF E Pruvot E. - Lausanne, CHE Mansour M. - Boston, USA• trial Repolarization Alternans as a Dynamic Substrate A • ole of Imaging and Ablating Structural Obstacles to Treat R Promoting Wavebreaks in Human Paroxysmal and Persistent Human AF AF Marrouche N. F. - Salt Lake City, USA Narayan S. - San Diego, USA• ERCA2A Overexpression as a Molecular Intervention to S Suppress Repolarization Alternans and Susceptibility of Cardiac Fibrillation Cutler M. - Cleveland, USA• ntracardiac Repolarization Alternans/Variability Predicts I Imminent Ventricular Tachyarrhythmias in ICD Recipients Swerdlow C. D. - Los Angeles, USA www.cardiostim.com 27
  27. 27. Advance programComplex Electrophysiology and Ablation TechniquesFriday June 15 / 09:00 - 10:30 Computer ModellingMECHANISTICALLY-GUIDED APPROACHES TO Organized by Maxime Sermasant - Sophia Antipolis, FRA from INRIAHUMAN CARDIAC FIBRILLATION - PART III - (Institut National de Recherche en Informatique et Automatique)VENTRICULAR ARRHYTHMIASChair:Shivkumar K. - San Diego, USA Thursday June 14 / 11:00 - 12:30• rigger Mechanisms for Human Ventricular Fibrillation T COMPUTATIONAL ELECTROPHYSIOLOGY: Knecht S. - Bordeaux, FRA NOVEL TOOLS TO IMPROVE CLINICAL• ecent Developments in Defibrillation and in Understanding R Ventricular Fibrillation UNDERSTANDING Ideker R. - Birmingham, USA Chair: Panfilov A. V. - Gent, BEL• hat Is the Optimal Mapping Approach to Guide Ablation of W Rhode K. - London, GBR Human Ventricular Tachyarrhythmias? Shivkumar K. - Los Angeles, USA • lectrotonic Modulation of Cardiac Repolarization in Health E• ignal Processing Approaches to Guide Complex Ablation in S and Disease: Insights from a Combined Computational and the Atria and Ventricles Experimental Study Chen S.A. - Taipei, TWN Bernus O. - Bordeaux-Pessac, FRA• ignal Processing Insights into the Mechanisms of Human S • lectro-Mechanical Interaction – Is This Something the E Ventricular Arrhythmias Clinical Electrophysiologist Has to Care about or Is This only of Krummen D.E. - San Diego, USA Interest to the Cellular Researcher? Bijnens B. - Barcelona, ESP • lectrical and Structural Characteristics of Border Zone in E Infarcted Swine: Insights from 3D MR Image-Based Computer Models, Histopathology and EP Data Pop M. - Toronto, CAN • ardiac Radiofrequency Ablation Planning from Personalized C Biophysical Models Delingette H. - Sophia-Antipolis, FRA28 www.cardiostim.com
  28. 28. Cardiostim 2012Treatments of Atrial FibrillationAdvances and Controversies in Atrial Fibrillation (ACAF)Chairman:Naccarelli G. V. - Hershey, USABlanc J.J. - Brest, FRALévy S. - Marseille, FRAUnrestricted Educational Support: sanofi aventisThursday June 14 / 09:00 - 10:30 Thursday June 14 / 14:00 - 15:30ATRIAL FIBRILLATION I ATRIAL FIBRILLATION IIIChair: Chair:Naccarelli G. V. - Hershey, USA Santini M. - Rome, ITABoriani G. - Bologna, ITA Breithardt G. - Münster, DEU• arly Attempts at Rhythm Control Slows Progression of AF E • ovel Anticoagulants: Where Are We in 2012? N Crijns H. J. - Maastricht, NLD Naccarelli G. V. - Hershey, USA• as Basic Science Helped Us Develop Better Pharmacologic H • an Newer Anticoagulants Be Used Safely for Cardioversion C and Ablative Therapies for AF? of AF Patients? Allessie M. - Maastricht, NLD Aliot E. - Nancy, FRA• pstream Therapy of AF – Is It All over but the Shouting? U • ntiarrhythmic/Anticoagulant Drug Interactions: What Do We A Dorian P. - Toronto, CAN Know? Tamargo J. - Madrid, ESPThursday June 14 / 11:00 - 12:30 Thursday June 14 / 16:00 - 17:30ATRIAL FIBRILLATION II ATRIAL FIBRILLATION IVChair: Chair:van Gelder I. C. - Groningen, NLD Lévy S. - Marseille, FRACapucci A. - Ancona, ITA Vardas P. E. - Heraklion, GRC• ronedarone in 2012: What is New? D • symptomatic AF: Prognostic Implications A Le Heuzey J. Y. - Paris , FRA Blanc J. J. - Brest, FRA• ALLAS: Why Was It Performed? Where Are We? P • s Catheter Ablation of AF Prothrombotic or Antithrombotic? I Hohnloser S. - Frankfurt, DEU Packer D. L. - Rochester, USA• ronedarone and Ranolazine: Is a Combination Drug a Good D • ole of Novel Anticoagulants During AF Ablation Procedures? R Idea ? Cappato R. - San Donato Milanese (MI), ITA Antzelevitch C. - Utica, USA www.cardiostim.com 29

×